-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cidara Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
- Cidara Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 4.56M shares, a 1.29% increase year-over-year.
- Cidara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 87.4M shares, a 25.2% increase from 2022.
- Cidara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 69.9M shares, a 33.2% increase from 2021.
- Cidara Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 52.5M shares, a 26.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)